Etzer Darout Score: 32
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+16.8%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
56%
40 W / 31 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
60%
37 W / 25 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
11%
7 W / 55 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
2%
1 W / 61 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
52%
28 W / 26 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
54%
36 W / 31 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
4 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 06, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$234.00
Est. +10%
|
$212.26 | $243.32 |
Target Met
|
$230.56
+8.6%
|
| Apr 27, 2026 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$160.00
Est. +99%
|
$80.35 | $91.00 |
Pending
|
$69.89
-13.0%
|
| Apr 20, 2026 |
Janux Therapeutics Inc
JANX
|
SELL |
$14.00
Est. +12%
|
$15.82 | $12.99 (Low) |
Target Met
|
$13.56
+14.3%
|
| Apr 20, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$225.00
Est. +11%
|
$203.42 | $243.32 |
Target Met
|
$230.56
+13.3%
|
| Mar 09, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$224.00
Est. +21%
|
$185.40 | $243.32 |
Target Met
|
$230.56
+24.4%
|
| Mar 03, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$53.00
Est. +20%
|
$44.31 | $52.19 |
Precision Hit (±3%)
|
$44.18
-0.3%
|
| Feb 26, 2026 |
C4 Therapeutics Inc
CCCC
|
BUY |
$7.00
Est. +149%
|
$2.81 | $4.60 |
Pending
|
$3.90
+38.8%
|
| Feb 04, 2026 |
Exelixis Inc
EXEL
|
BUY |
$44.00
Est. +3%
|
$42.59 | $53.93 |
Target Met
|
$53.13
+24.7%
|
| Feb 04, 2026 |
Vir Biotechnology Inc
VIR
|
BUY |
$24.00
Est. +213%
|
$7.68 | $11.66 |
Pending
|
$8.61
+12.1%
|
| Jan 20, 2026 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$8.00
Est. +48%
|
$5.39 | $8.20 |
Precision Hit (±3%)
|
$3.01
-44.2%
|
| Dec 17, 2025 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$52.00
Est. +17%
|
$44.32 | $52.19 |
Bullseye Hit (±1%)
|
$44.18
-0.3%
|
| Dec 17, 2025 |
Summit Therapeutics Inc
SMMT
|
BUY |
$18.00
Est. +4%
|
$17.23 | $29.23 |
Target Met
|
$14.01
-18.7%
|
| Dec 17, 2025 |
AnaptysBio Inc
ANAB
|
BUY |
$55.00
Est. +22%
|
$45.03 | $72.27 |
Target Met
|
$56.07
+24.5%
|
| Dec 09, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$56.00
Est. +39%
|
$40.23 | $53.18 |
Pending
|
$52.95
+31.6%
|
| Nov 25, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$36.00
Est. +28%
|
$28.04 | $53.18 |
Target Met
|
$52.95
+88.8%
|
| Nov 24, 2025 |
Kura Oncology Inc
KURA
|
BUY |
$28.00
Est. +151%
|
$11.17 | $12.32 |
Pending
|
$9.05
-19.0%
|
| Nov 17, 2025 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$152.00
Est. +41%
|
$108.00 | $123.62 |
Pending
|
$123.25
+14.1%
|
| Nov 05, 2025 |
Exelixis Inc
EXEL
|
BUY |
$41.00
Est. +8%
|
$37.90 | $53.93 |
Target Met
|
$53.13
+40.2%
|
| Oct 29, 2025 |
Xencor Inc
XNCR
|
BUY |
$23.00
Est. +61%
|
$14.25 | $18.69 |
Pending
|
$12.33
-13.5%
|
| Oct 22, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$14.00
Est. +86%
|
$7.53 | $53.18 |
Target Met
|
$52.95
+603.2%
|
| Oct 21, 2025 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$6.00
Est. +60%
|
$3.74 | $8.20 |
Target Met
|
$3.01
-19.5%
|
| Oct 13, 2025 |
Abivax - ADR
ABVX
|
BUY |
$142.00
Est. +51%
|
$93.77 | $148.83 |
Target Met
|
$96.55
+3.0%
|
| Oct 13, 2025 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$125.00
Est. +42%
|
$87.82 | $104.00 |
Pending
|
$59.77
-31.9%
|
| Sep 24, 2025 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$44.00
Est. +32%
|
$33.39 | $52.19 |
Target Met
|
$44.18
+32.3%
|
| Sep 22, 2025 |
C4 Therapeutics Inc
CCCC
|
BUY |
$10.00
Est. +216%
|
$3.16 | $4.60 |
Pending
|
$3.90
+23.4%
|
| Sep 16, 2025 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$3.50
Est. +79%
|
$1.96 | $8.20 |
Target Met
|
$3.01
+53.6%
|
| May 23, 2025 |
Merus N.V
MRUS
|
BUY |
$110.00
Est. +99%
|
$55.14 | $97.02 |
Miss
|
$90.00
+63.2%
|
| Mar 12, 2025 |
Arvinas Inc
ARVN
|
BUY |
$20.00
Est. +137%
|
$8.43 | $16.14 |
Miss
|
$7.58
-10.1%
|
| Dec 05, 2024 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$55.00
Est. +25%
|
$44.08 | $68.80 |
Target Met
|
$86.21
+95.6%
|
| Dec 05, 2024 |
Protagonist Therapeutics Inc
PTGX
|
BUY |
$62.00
Est. +49%
|
$41.68 | $93.25 |
Target Met
|
$109.78
+163.4%
|
| Dec 05, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$35.00
Est. +74%
|
$20.06 | $22.95 |
Miss
|
$16.95
-15.5%
|
| Dec 05, 2024 |
Jasper Therapeutics Inc
JSPR
|
BUY |
$63.00
Est. +193%
|
$21.53 | $23.89 |
Miss
|
$0.46
-97.9%
|
| Dec 05, 2024 |
Tourmaline Bio Inc
TRML
|
BUY |
$50.00
Est. +108%
|
$24.03 | $48.26 |
Miss
|
$47.98
+99.7%
|
| Dec 05, 2024 |
Q32 Bio Inc.
QTTB
|
BUY |
$64.00
Est. +170%
|
$23.69 | $28.06 |
Miss
|
$12.64
-46.6%
|
| Dec 05, 2024 |
IGM Biosciences Inc
IGMS
|
BUY |
$21.00
Est. +122%
|
$9.46 | $10.80 |
Miss
|
$1.27
-86.6%
|
| Dec 02, 2024 |
Merus N.V
MRUS
|
BUY |
$95.00
Est. +96%
|
$48.53 | $96.30 |
Precision Hit (±3%)
|
$90.00
+85.5%
|
| Nov 14, 2024 |
Acrivon Therapeutics Inc
ACRV
|
BUY |
$27.00
Est. +241%
|
$7.92 | $8.35 |
Miss
|
$1.48
-81.3%
|
| Nov 13, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$134.00
Est. +91%
|
$69.99 | $104.90 |
Miss
|
$123.25
+76.1%
|
| Nov 13, 2024 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$39.00
Est. +45%
|
$26.97 | $46.98 |
Target Met
|
$44.18
+63.8%
|
| Nov 13, 2024 |
Fate Therapeutics Inc
FATE
|
BUY |
$5.00
Est. +48%
|
$3.37 | $3.50 |
Miss
|
$2.06
-38.9%
|
| Nov 13, 2024 |
Astrazeneca plc - ADR
AZN
|
BUY |
$88.00
Est. +8%
|
$81.19 | $89.43 |
Precision Hit (±3%)
|
$178.75
+120.2%
|
| Nov 11, 2024 |
Y-Mabs Therapeutics Inc
YMAB
|
BUY |
$24.00
Est. +59%
|
$15.06 | $15.69 |
Miss
|
$8.61
-42.8%
|
| Nov 08, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$3.68
Est. +238%
|
$1.09 | $4.62 |
Target Met
|
$3.01
+176.1%
|
| Nov 04, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$126.00
Est. +16%
|
$108.97 | $129.27 |
Precision Hit (±3%)
|
$90.54
-16.9%
|
| Oct 30, 2024 |
Exelixis Inc
EXEL
|
BUY |
$36.00
Est. +11%
|
$32.56 | $49.40 |
Target Met
|
$53.13
+63.2%
|
| Oct 30, 2024 |
Novartis AG - ADR
NVS
|
BUY |
$120.00
Est. +9%
|
$109.91 | $133.56 |
Target Met
|
$153.07
+39.3%
|
| Oct 11, 2024 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$38.00
Est. +50%
|
$25.27 | $46.98 |
Target Met
|
$44.18
+74.8%
|
| Sep 19, 2024 |
C4 Therapeutics Inc
CCCC
|
BUY |
$20.00
Est. +191%
|
$6.87 | $7.14 |
Miss
|
$3.90
-43.2%
|
| Sep 16, 2024 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$26.00
Est. +190%
|
$8.96 | $10.69 |
Miss
|
$52.95
+491.0%
|
| Sep 16, 2024 |
Acrivon Therapeutics Inc
ACRV
|
BUY |
$28.00
Est. +214%
|
$8.91 | $10.00 |
Miss
|
$1.48
-83.4%
|
| Sep 11, 2024 |
Astrazeneca plc - ADR
AZN
|
BUY |
$89.00
Est. +11%
|
$79.94 | $82.41 |
Miss
|
$178.75
+123.6%
|
| Aug 09, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$3.56
Est. +202%
|
$1.18 | $3.10 |
Miss
|
$3.01
+155.1%
|
| Aug 09, 2024 |
Genmab - ADR
GMAB
|
BUY |
$46.00
Est. +70%
|
$27.07 | $27.94 |
Miss
|
$25.08
-7.4%
|
| Jul 19, 2024 |
Novartis AG - ADR
NVS
|
BUY |
$118.00
Est. +11%
|
$106.13 | $124.83 |
Target Met
|
$153.07
+44.2%
|
| Jun 14, 2024 |
Xencor Inc
XNCR
|
BUY |
$32.00
Est. +53%
|
$20.90 | $27.24 |
Miss
|
$12.33
-41.0%
|
| Jun 13, 2024 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$31.00
Est. +230%
|
$9.39 | $46.98 |
Target Met
|
$44.18
+370.5%
|
| Jun 04, 2024 |
Merus N.V
MRUS
|
BUY |
$91.00
Est. +72%
|
$52.94 | $62.98 |
Miss
|
$90.00
+70.0%
|
| May 28, 2024 |
Merus N.V
MRUS
|
BUY |
$84.00
Est. +56%
|
$53.86 | $59.38 |
Miss
|
$90.00
+67.1%
|
| May 28, 2024 |
Astrazeneca plc - ADR
AZN
|
BUY |
$82.00
Est. +7%
|
$76.74 | $87.67 |
Target Met
|
$178.75
+132.9%
|
| May 24, 2024 |
Merus N.V
MRUS
|
SELL |
$58.00
Est. +1%
|
$58.61 | $33.20 (Low) |
Target Met
|
$90.00
-53.6%
|
| May 23, 2024 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$29.00
Est. +159%
|
$11.18 | $46.98 |
Target Met
|
$44.18
+295.2%
|
| May 14, 2024 |
Acrivon Therapeutics Inc
ACRV
|
BUY |
$25.00
Est. +194%
|
$8.51 | $10.16 |
Miss
|
$1.48
-82.6%
|
| May 10, 2024 |
Fate Therapeutics Inc
FATE
|
BUY |
$6.00
Est. +55%
|
$3.87 | $5.91 |
Precision Hit (±3%)
|
$2.06
-46.8%
|
| May 10, 2024 |
Macrogenics Inc
MGNX
|
SELL |
$8.00
Est. +45%
|
$14.67 | $1.00 (Low) |
Target Met
|
$3.96
+73.0%
|
| May 09, 2024 |
CytomX Therapeutics Inc
CTMX
|
SELL |
$3.59
Est. +14%
|
$4.19 | $0.40 (Low) |
Target Met
|
$3.01
+28.2%
|
| May 07, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$122.00
Est. +33%
|
$91.53 | $131.49 |
Target Met
|
$90.54
-1.1%
|
| Apr 05, 2024 |
Y-Mabs Therapeutics Inc
YMAB
|
BUY |
$26.00
Est. +79%
|
$14.56 | $16.10 |
Miss
|
$8.61
-40.9%
|
| Mar 21, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$123.00
Est. +34%
|
$91.99 | $131.49 |
Target Met
|
$90.54
-1.6%
|
| Mar 15, 2024 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$19.00
Est. +164%
|
$7.20 | $11.40 |
Miss
|
$52.95
+635.4%
|
| Mar 12, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$3.25
Est. +51%
|
$2.15 | $1.52 |
Miss
|
$3.01
+40.0%
|
| Feb 23, 2024 |
Genmab - ADR
GMAB
|
BUY |
$48.00
Est. +65%
|
$29.16 | $28.56 |
Miss
|
$25.08
-14.0%
|
Jazz Pharmaceuticals plc
JAZZ
May 06, 2026
Signal & Target
BUY
$234.00
Start Price
$212.26
Best Price (1Y)
$243.32
Current Price
$230.56
Return
+8.6%
Oruka Therapeutics, Inc.
ORKA
Apr 27, 2026
Signal & Target
BUY
$160.00
Start Price
$80.35
Best Price (1Y)
$91.00
Current Price
$69.89
Return
-13.0%
Janux Therapeutics Inc
JANX
Apr 20, 2026
Signal & Target
SELL
$14.00
Start Price
$15.82
Best Price (1Y)
$12.99
Current Price
$13.56
Return
+14.3%
Jazz Pharmaceuticals plc
JAZZ
Apr 20, 2026
Signal & Target
BUY
$225.00
Start Price
$203.42
Best Price (1Y)
$243.32
Current Price
$230.56
Return
+13.3%
Jazz Pharmaceuticals plc
JAZZ
Mar 09, 2026
Signal & Target
BUY
$224.00
Start Price
$185.40
Best Price (1Y)
$243.32
Current Price
$230.56
Return
+24.4%
Scholar Rock Holding Corp
SRRK
Mar 03, 2026
Signal & Target
BUY
$53.00
Start Price
$44.31
Best Price (1Y)
$52.19
Current Price
$44.18
Return
-0.3%
C4 Therapeutics Inc
CCCC
Feb 26, 2026
Signal & Target
BUY
$7.00
Start Price
$2.81
Best Price (1Y)
$4.60
Current Price
$3.90
Return
+38.8%
Exelixis Inc
EXEL
Feb 04, 2026
Signal & Target
BUY
$44.00
Start Price
$42.59
Best Price (1Y)
$53.93
Current Price
$53.13
Return
+24.7%
Vir Biotechnology Inc
VIR
Feb 04, 2026
Signal & Target
BUY
$24.00
Start Price
$7.68
Best Price (1Y)
$11.66
Current Price
$8.61
Return
+12.1%
CytomX Therapeutics Inc
CTMX
Jan 20, 2026
Signal & Target
BUY
$8.00
Start Price
$5.39
Best Price (1Y)
$8.20
Current Price
$3.01
Return
-44.2%
Scholar Rock Holding Corp
SRRK
Dec 17, 2025
Signal & Target
BUY
$52.00
Start Price
$44.32
Best Price (1Y)
$52.19
Current Price
$44.18
Return
-0.3%
Summit Therapeutics Inc
SMMT
Dec 17, 2025
Signal & Target
BUY
$18.00
Start Price
$17.23
Best Price (1Y)
$29.23
Current Price
$14.01
Return
-18.7%
AnaptysBio Inc
ANAB
Dec 17, 2025
Signal & Target
BUY
$55.00
Start Price
$45.03
Best Price (1Y)
$72.27
Current Price
$56.07
Return
+24.5%
Terns Pharmaceuticals Inc
TERN
Dec 09, 2025
Signal & Target
BUY
$56.00
Start Price
$40.23
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+31.6%
Terns Pharmaceuticals Inc
TERN
Nov 25, 2025
Signal & Target
BUY
$36.00
Start Price
$28.04
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+88.8%
Kura Oncology Inc
KURA
Nov 24, 2025
Signal & Target
BUY
$28.00
Start Price
$11.17
Best Price (1Y)
$12.32
Current Price
$9.05
Return
-19.0%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Nov 17, 2025
Signal & Target
BUY
$152.00
Start Price
$108.00
Best Price (1Y)
$123.62
Current Price
$123.25
Return
+14.1%
Exelixis Inc
EXEL
Nov 05, 2025
Signal & Target
BUY
$41.00
Start Price
$37.90
Best Price (1Y)
$53.93
Current Price
$53.13
Return
+40.2%
Xencor Inc
XNCR
Oct 29, 2025
Signal & Target
BUY
$23.00
Start Price
$14.25
Best Price (1Y)
$18.69
Current Price
$12.33
Return
-13.5%
Terns Pharmaceuticals Inc
TERN
Oct 22, 2025
Signal & Target
BUY
$14.00
Start Price
$7.53
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+603.2%
CytomX Therapeutics Inc
CTMX
Oct 21, 2025
Signal & Target
BUY
$6.00
Start Price
$3.74
Best Price (1Y)
$8.20
Current Price
$3.01
Return
-19.5%
Abivax - ADR
ABVX
Oct 13, 2025
Signal & Target
BUY
$142.00
Start Price
$93.77
Best Price (1Y)
$148.83
Current Price
$96.55
Return
+3.0%
Monopar Therapeutics Inc
MNPR
Oct 13, 2025
Signal & Target
BUY
$125.00
Start Price
$87.82
Best Price (1Y)
$104.00
Current Price
$59.77
Return
-31.9%
Scholar Rock Holding Corp
SRRK
Sep 24, 2025
Signal & Target
BUY
$44.00
Start Price
$33.39
Best Price (1Y)
$52.19
Current Price
$44.18
Return
+32.3%
C4 Therapeutics Inc
CCCC
Sep 22, 2025
Signal & Target
BUY
$10.00
Start Price
$3.16
Best Price (1Y)
$4.60
Current Price
$3.90
Return
+23.4%
CytomX Therapeutics Inc
CTMX
Sep 16, 2025
Signal & Target
BUY
$3.50
Start Price
$1.96
Best Price (1Y)
$8.20
Current Price
$3.01
Return
+53.6%
Merus N.V
MRUS
May 23, 2025
Signal & Target
BUY
$110.00
Start Price
$55.14
Best Price (1Y)
$97.02
Current Price
$90.00
Return
+63.2%
Arvinas Inc
ARVN
Mar 12, 2025
Signal & Target
BUY
$20.00
Start Price
$8.43
Best Price (1Y)
$16.14
Current Price
$7.58
Return
-10.1%
Kymera Therapeutics Inc
KYMR
Dec 05, 2024
Signal & Target
BUY
$55.00
Start Price
$44.08
Best Price (1Y)
$68.80
Current Price
$86.21
Return
+95.6%
Protagonist Therapeutics Inc
PTGX
Dec 05, 2024
Signal & Target
BUY
$62.00
Start Price
$41.68
Best Price (1Y)
$93.25
Current Price
$109.78
Return
+163.4%
Nurix Therapeutics Inc
NRIX
Dec 05, 2024
Signal & Target
BUY
$35.00
Start Price
$20.06
Best Price (1Y)
$22.95
Current Price
$16.95
Return
-15.5%
Jasper Therapeutics Inc
JSPR
Dec 05, 2024
Signal & Target
BUY
$63.00
Start Price
$21.53
Best Price (1Y)
$23.89
Current Price
$0.46
Return
-97.9%
Tourmaline Bio Inc
TRML
Dec 05, 2024
Signal & Target
BUY
$50.00
Start Price
$24.03
Best Price (1Y)
$48.26
Current Price
$47.98
Return
+99.7%
Q32 Bio Inc.
QTTB
Dec 05, 2024
Signal & Target
BUY
$64.00
Start Price
$23.69
Best Price (1Y)
$28.06
Current Price
$12.64
Return
-46.6%
IGM Biosciences Inc
IGMS
Dec 05, 2024
Signal & Target
BUY
$21.00
Start Price
$9.46
Best Price (1Y)
$10.80
Current Price
$1.27
Return
-86.6%
Merus N.V
MRUS
Dec 02, 2024
Signal & Target
BUY
$95.00
Start Price
$48.53
Best Price (1Y)
$96.30
Current Price
$90.00
Return
+85.5%
Acrivon Therapeutics Inc
ACRV
Nov 14, 2024
Signal & Target
BUY
$27.00
Start Price
$7.92
Best Price (1Y)
$8.35
Current Price
$1.48
Return
-81.3%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Nov 13, 2024
Signal & Target
BUY
$134.00
Start Price
$69.99
Best Price (1Y)
$104.90
Current Price
$123.25
Return
+76.1%
Scholar Rock Holding Corp
SRRK
Nov 13, 2024
Signal & Target
BUY
$39.00
Start Price
$26.97
Best Price (1Y)
$46.98
Current Price
$44.18
Return
+63.8%
Fate Therapeutics Inc
FATE
Nov 13, 2024
Signal & Target
BUY
$5.00
Start Price
$3.37
Best Price (1Y)
$3.50
Current Price
$2.06
Return
-38.9%
Astrazeneca plc - ADR
AZN
Nov 13, 2024
Signal & Target
BUY
$88.00
Start Price
$81.19
Best Price (1Y)
$89.43
Current Price
$178.75
Return
+120.2%
Y-Mabs Therapeutics Inc
YMAB
Nov 11, 2024
Signal & Target
BUY
$24.00
Start Price
$15.06
Best Price (1Y)
$15.69
Current Price
$8.61
Return
-42.8%
CytomX Therapeutics Inc
CTMX
Nov 08, 2024
Signal & Target
BUY
$3.68
Start Price
$1.09
Best Price (1Y)
$4.62
Current Price
$3.01
Return
+176.1%
BioNTech SE - ADR
BNTX
Nov 04, 2024
Signal & Target
BUY
$126.00
Start Price
$108.97
Best Price (1Y)
$129.27
Current Price
$90.54
Return
-16.9%
Exelixis Inc
EXEL
Oct 30, 2024
Signal & Target
BUY
$36.00
Start Price
$32.56
Best Price (1Y)
$49.40
Current Price
$53.13
Return
+63.2%
Novartis AG - ADR
NVS
Oct 30, 2024
Signal & Target
BUY
$120.00
Start Price
$109.91
Best Price (1Y)
$133.56
Current Price
$153.07
Return
+39.3%
Scholar Rock Holding Corp
SRRK
Oct 11, 2024
Signal & Target
BUY
$38.00
Start Price
$25.27
Best Price (1Y)
$46.98
Current Price
$44.18
Return
+74.8%
C4 Therapeutics Inc
CCCC
Sep 19, 2024
Signal & Target
BUY
$20.00
Start Price
$6.87
Best Price (1Y)
$7.14
Current Price
$3.90
Return
-43.2%
Terns Pharmaceuticals Inc
TERN
Sep 16, 2024
Signal & Target
BUY
$26.00
Start Price
$8.96
Best Price (1Y)
$10.69
Current Price
$52.95
Return
+491.0%
Acrivon Therapeutics Inc
ACRV
Sep 16, 2024
Signal & Target
BUY
$28.00
Start Price
$8.91
Best Price (1Y)
$10.00
Current Price
$1.48
Return
-83.4%
Astrazeneca plc - ADR
AZN
Sep 11, 2024
Signal & Target
BUY
$89.00
Start Price
$79.94
Best Price (1Y)
$82.41
Current Price
$178.75
Return
+123.6%
CytomX Therapeutics Inc
CTMX
Aug 09, 2024
Signal & Target
BUY
$3.56
Start Price
$1.18
Best Price (1Y)
$3.10
Current Price
$3.01
Return
+155.1%
Genmab - ADR
GMAB
Aug 09, 2024
Signal & Target
BUY
$46.00
Start Price
$27.07
Best Price (1Y)
$27.94
Current Price
$25.08
Return
-7.4%
Novartis AG - ADR
NVS
Jul 19, 2024
Signal & Target
BUY
$118.00
Start Price
$106.13
Best Price (1Y)
$124.83
Current Price
$153.07
Return
+44.2%
Xencor Inc
XNCR
Jun 14, 2024
Signal & Target
BUY
$32.00
Start Price
$20.90
Best Price (1Y)
$27.24
Current Price
$12.33
Return
-41.0%
Scholar Rock Holding Corp
SRRK
Jun 13, 2024
Signal & Target
BUY
$31.00
Start Price
$9.39
Best Price (1Y)
$46.98
Current Price
$44.18
Return
+370.5%
Merus N.V
MRUS
Jun 04, 2024
Signal & Target
BUY
$91.00
Start Price
$52.94
Best Price (1Y)
$62.98
Current Price
$90.00
Return
+70.0%
Merus N.V
MRUS
May 28, 2024
Signal & Target
BUY
$84.00
Start Price
$53.86
Best Price (1Y)
$59.38
Current Price
$90.00
Return
+67.1%
Astrazeneca plc - ADR
AZN
May 28, 2024
Signal & Target
BUY
$82.00
Start Price
$76.74
Best Price (1Y)
$87.67
Current Price
$178.75
Return
+132.9%
Merus N.V
MRUS
May 24, 2024
Signal & Target
SELL
$58.00
Start Price
$58.61
Best Price (1Y)
$33.20
Current Price
$90.00
Return
-53.6%
Scholar Rock Holding Corp
SRRK
May 23, 2024
Signal & Target
BUY
$29.00
Start Price
$11.18
Best Price (1Y)
$46.98
Current Price
$44.18
Return
+295.2%
Acrivon Therapeutics Inc
ACRV
May 14, 2024
Signal & Target
BUY
$25.00
Start Price
$8.51
Best Price (1Y)
$10.16
Current Price
$1.48
Return
-82.6%
Fate Therapeutics Inc
FATE
May 10, 2024
Signal & Target
BUY
$6.00
Start Price
$3.87
Best Price (1Y)
$5.91
Current Price
$2.06
Return
-46.8%
Macrogenics Inc
MGNX
May 10, 2024
Signal & Target
SELL
$8.00
Start Price
$14.67
Best Price (1Y)
$1.00
Current Price
$3.96
Return
+73.0%
CytomX Therapeutics Inc
CTMX
May 09, 2024
Signal & Target
SELL
$3.59
Start Price
$4.19
Best Price (1Y)
$0.40
Current Price
$3.01
Return
+28.2%
BioNTech SE - ADR
BNTX
May 07, 2024
Signal & Target
BUY
$122.00
Start Price
$91.53
Best Price (1Y)
$131.49
Current Price
$90.54
Return
-1.1%
Y-Mabs Therapeutics Inc
YMAB
Apr 05, 2024
Signal & Target
BUY
$26.00
Start Price
$14.56
Best Price (1Y)
$16.10
Current Price
$8.61
Return
-40.9%
BioNTech SE - ADR
BNTX
Mar 21, 2024
Signal & Target
BUY
$123.00
Start Price
$91.99
Best Price (1Y)
$131.49
Current Price
$90.54
Return
-1.6%
Terns Pharmaceuticals Inc
TERN
Mar 15, 2024
Signal & Target
BUY
$19.00
Start Price
$7.20
Best Price (1Y)
$11.40
Current Price
$52.95
Return
+635.4%
CytomX Therapeutics Inc
CTMX
Mar 12, 2024
Signal & Target
BUY
$3.25
Start Price
$2.15
Best Price (1Y)
$1.52
Current Price
$3.01
Return
+40.0%
Genmab - ADR
GMAB
Feb 23, 2024
Signal & Target
BUY
$48.00
Start Price
$29.16
Best Price (1Y)
$28.56
Current Price
$25.08
Return
-14.0%